In the BioHarmony Drug Report Database
Anakinra
Kineret (anakinra) is a protein pharmaceutical. Anakinra was first approved as Kineret on 2001-11-14. It is used to treat cryopyrin-associated periodic syndromes and rheumatoid arthritis in the USA. It has been approved in Europe to treat rheumatoid arthritis. The pharmaceutical is active against interleukin-1 receptor type 1.
Trade Name
|
Kineret |
|---|---|
Common Name
|
anakinra |
ChEMBL ID
|
CHEMBL1201570 |
Indication
|
cryopyrin-associated periodic syndromes, rheumatoid arthritis |
Drug Class
|
Interleukin-1 (IL-1) receptor antagonists |
Image (chem structure or protein)
